000 01437 a2200433 4500
005 20250513144524.0
264 0 _c19980708
008 199807s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/s0041-1345(98)00239-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSato, S
245 0 0 _aSpecificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
_h[electronic resource]
260 _bTransplantation proceedings
_cJun 1998
300 _a1274-5 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aDrug Monitoring
_xmethods
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aHumans
650 0 4 _aImmunoenzyme Techniques
650 0 4 _aImmunosuppressive Agents
_xblood
650 0 4 _aKidney Transplantation
_ximmunology
650 0 4 _aMass Spectrometry
650 0 4 _aPostoperative Period
650 0 4 _aTacrolimus
_xblood
650 0 4 _aTime Factors
700 1 _aFuchinoue, S
700 1 _aTojimbara, T
700 1 _aFujita, S
700 1 _aNakajima, I
700 1 _aAgishi, T
700 1 _aHayashi, T
700 1 _aTeramura, Y
700 1 _aFujita, E
700 1 _aIwasaki, K
773 0 _tTransplantation proceedings
_gvol. 30
_gno. 4
_gp. 1274-5
856 4 0 _uhttps://doi.org/10.1016/s0041-1345(98)00239-5
_zAvailable from publisher's website
999 _c9602797
_d9602797